US 10172789
Compositions for transdermal delivery of mTOR inhibitors
granted A61KA61K31/436A61K47/10
Quick answer
US patent 10172789 (Compositions for transdermal delivery of mTOR inhibitors) held by PALVELLA THERAPEUTICS, INC. expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PALVELLA THERAPEUTICS, INC.
- Grant date
- Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/436, A61K47/10, A61K47/12, A61K47/32